Skip to content
You are not logged in |Login  
     
Limit search to available items
Record:   Prev Next
Resources
More Information
Bestseller
BestsellerE-book

Title Controlled human inhalation-exposure studies at EPA / Committee on Assessing Toxicologic Risks to Human Subjects Used in Controlled Exposure Studies of Environmental Pollutants, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies.

Publication Info. Washington, DC : The National Academies Press, [2017]

Item Status

Description 1 online resource (1 PDF file (xv, 141 pages)) : illustrations
Physical Medium polychrome
Description text file
Note "A report of the National Academies of Sciences, Engineering, Medicine."
Bibliography Includes bibliographical references.
Summary The U.S. Environmental Protection Agency (EPA) has a mission and regulatory responsibility to protect human health and the environment. EPA's pursuit of that goal includes a variety of research activities involving human subjects, such as epidemiologic studies and surveys. Those research activities also involve studies of individuals who volunteer to be exposed to air pollutants intentionally in controlled laboratory settings so that measurements can be made of transient and reversible biomarker or physiologic responses to those exposures that can indicate pathways of toxicity and mechanisms of air-pollution responses. The results of those controlled human inhalation exposure (CHIE) studies, also referred to as human clinical studies or human challenge studies, are used to inform policy decisions and help establish or revise standards to protect public health and improve air quality. Controlled Human Inhalation-Exposure Studies at EPA addresses scientific issues and provides guidance on the conduct of CHIE studies. This report assesses the utility of CHIE studies to inform and reduce uncertainties in setting air-pollution standards to protect public health and assess whether continuation of such studies is warranted. It also evaluates the potential health risks to test subjects who participated in recent studies of air pollutants at EPA's clinical research facility.
Funding This activity was supported by Contract No. EP-C-14-005 from the U.S. Environmental Protection Agency. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
Contents Introduction -- Foundational aspects of human-subjects research -- Value of controlled human inhalation exposure studies -- Assessment of controlled human inhalation exposure studies at EPA and associated adverse events -- The continued conduct of controlled human inhalation exposure studies by EPA -- Characterizing risks to subjects in controlled human inhalation exposure studies -- Communication about informed consent in controlled humanm inhalation exposure studies -- Reference -- Appendix A: Biographical information on the Committee on Assessing Toxicologic Risks to Human Subjects Used in Controlled Expposure Studies of Environmental Pollutants -- Appendix B: Public information-Gathering sessions -- Appendix C: Assessment of eight controlled human exposure studies.
Local Note eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - North America
Subject United States. Environmental Protection Agency.
United States. Environmental Protection Agency.
Pulmonary toxicology.
Pulmonary toxicology.
Pollutants -- Health aspects.
Pollutants -- Health aspects.
Pollutants.
Risk assessment.
United States.
Risk assessment.
risk assessment.
Genre/Form Technical reports.
Technical reports.
Added Author National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Assessing Toxicologic Risks to Human Subjects Used in Controlled Exposure Studies of Environmental Pollutants, issuing body.
National Academies of Sciences, Engineering, and Medicine (U.S.), issuing body.
Other Form: Print version: Controlled Human Inhalation-Exposure Studies at EPA. Washington, D.C. : National Academies Press, [2017] 9780309452496
ISBN 0309452503
9780309452502 (electronic book)
9780309452496
030945249X
Standard No. 10.17226/24618